Valeant has gained FDA approval for psoriasis drug Siliq – but side effect warnings about suicidal ideation look set to limit sales. Originally developed by Amgen and AstraZeneca, a suicidal ...

BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...

After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb ( BLCO) chairman ...

On Wednesday embattled drug maker Valeant will present its guidance for 2016 in a four-hour Investor Day conference call that starts at 8:00 am EST. It will have a lot of explaining to do ...

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures, and markets a range of branded and generic pharmaceuticals, over-the ...

The FDA has finally approved Valeant’s eye drug Vyzulta after the company finally satisfied the regulator’s concerns over its manufacturing facility in Florida. The Quebec-based company’s ...

Bausch Health Cos. convinced a federal court to dismiss, for now, allegations that executives misled investors about the spin-off of Bausch + Lomb, and other corporate liabilities.

At a town hall meeting last night, presidential candidate Hillary Clinton vowed to "go after," Valeant Pharmaceuticals, after a woman handed her a note about her diabetes medication. The note said ...

Valeant Pharmaceuticals' outgoing CEO Mike Pearson, the company's former interim CEO Howard Schiller, and board member and hedge fund billionaire Bill Ackman, are all testifying before the US ...